Table 1

Patient flow through the study

Budesonide 3 mgBudesonide 9 mgPrednisolone 7.5 mgPlaceboTotal
Of 150 patients enrolled, five were not randomised because they were ineligible and two for other reasons.
*Five patients had two reasons for discontinuation.
Lost to follow up01001
Included in intention to treat analysis37353931142
Discontinued study medication763723
Symptom deterioration*531312
Adverse event*12126
Other reasons*30126
Completed study medication30303624120